Betahistine vs placebo/no treatmentChange in vertigo frequency · Ménière’s disease2 findings from 1 reviewSystemic pharmacological interventions for Ménière’s disease 2023 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 117 participantsVery lowSystemic pharmacological interventions for Ménière’s disease 2023 · Cochrane Headline outcomes onlyno estimate extracted1 study · 214 participantsVery low
Diuretic vs placebo/no treatmentChange in vertigo frequency · Ménière’s disease1 finding from 1 reviewSystemic pharmacological interventions for Ménière’s disease 2023 · Cochrane Headline outcomes onlyno estimate extracted1 study · 220 participantsVery low
Beta‐blockers vs placeboChange in vertigo frequency · people with vestibular migraine1 finding from 1 reviewPharmacological interventions for prophylaxis of vestibular migraine 2023 · Cochrane Headline outcomes onlyno estimate extracted1 study · 114 participantsLow
Dietary intervention (probiotics) vs placeboChange in vertigo frequency · adults with vestibular migraine1 finding from 1 reviewNon‐pharmacological interventions for prophylaxis of vestibular migraine 2023 · Cochrane Headline outcomes onlyno estimate extracted1 study · 204 participantsVery low
Intratympanic corticosteroids vs placebo/no treatmentChange in vertigo frequency · Ménière’s disease3 findings from 1 reviewIntratympanic corticosteroids for Ménière’s disease 2023 · Cochrane Headline outcomes onlyno estimate extracted3 studies · 472 participantsLowIntratympanic corticosteroids for Ménière’s disease 2023 · Cochrane Headline outcomes onlyno estimate extracted1 study · 20 participantsVery lowIntratympanic corticosteroids for Ménière’s disease 2023 · Cochrane Headline outcomes onlyno estimate extracted1 study · 18 participantsVery low
Positive pressure therapy vs placeboChange in vertigo frequency · Ménière’s disease1 finding from 1 reviewPositive pressure therapy for Ménière’s disease 2023 · Cochrane Headline outcomes onlyno estimate extracted3 studies · 202 participantsVery low